Lv3
380 积分 2026-01-11 加入
Histone lactylation inhibits RARg expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling
8天前
已完结
Management of gliomas in patients with Lynch syndrome
12天前
已完结
European guidelines from the EHTG and ESCP for Lynch syndrome：an updated third edition of the Mallorca guidelines based on gene and gender
12天前
已完结
Is HLA type a possible cancer risk modifier in Lynch syndrome?
12天前
已关闭
Lynch Syndrome as a Spectrum of Four Distinct Genetic Disorders: Toward Genotype-Guided Precision Management in the NGS Era
12天前
已关闭
Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma
25天前
已完结
Mismatch Repair as a Dynamic and Clinically Actionable Vulnerability in Cancer
1个月前
已完结
Therapeutic targeting of mismatch repair-deficient cancers
1个月前
已完结
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
1个月前
已完结
First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study
1个月前
已完结
皖公网安备34019202002308
